Olaratumab
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity[1].
Product Specifications
CAS Number
[1024603-93-7]
Product Name Alternative
IMC-3G3; LY3012207
UNSPSC
12352203
Target
PDGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/olaratumab.html
Purity
95.0
Solubility
H2O
Smiles
[Olaratumab]
Molecular Weight
(147.12 kDa)
References & Citations
[1]Koji Matsuo, et al. Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma. Gynecol Oncol. 2014 Jan;132 (1) :166-75.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15151771 1 Vial
Lentiviral mouse Klrd1 shRNA (UAS) - Lentiviral mouse Klrd1 shRNA (UAS) plasmid
Ask
View Details 
MBS1256914-01 0.02 mg (E-Coli)
Recombinant Kosmotoga olearia Peptidyl-tRNA hydrolase (pth)
Ask
View Details MBS1256914-02 0.1 mg (E-Coli)
Recombinant Kosmotoga olearia Peptidyl-tRNA hydrolase (pth)
Ask
View Details